Allergy

Agency asks drugmaker for a repeat-dose study before approval

But biopsy should still remain standard, expert advised

Unanimous vote that the drug is ineffective

Pimecrolimus, tacrolimus, and moderate-potency topical corticosteroids come out on top

But they acknowledge that taking the only shelf-accessible product off the market raises issues

ERS statement suggests action for individual physicians with affected patients

Pozelimab reduced hospitalizations, albumin transfusions in CHAPLE disease patients

Also in TTHealthWatch: alpha-gal syndrome and AI for breast cancer screening

Selection praised by infectious disease groups

Clinicians say they would welcome guidelines for alpha-gal syndrome diagnosis, management

Constellation of comorbid allergic conditions common among children

Remission in stomach and duodenum, improved symptoms seen

Faster, cheaper process deemed safe for low-risk patients with questionable allergy label

Randomized trial shoots down a potential strategy for allergy prevention